{"Abbreviation":"6-OHDA","Aliases":["6-Hydroxydopamine","Oxidopamina","2,4,5-Trihydroxyphenethylamine","Oxidopaminum","Topamine","1,2,4-Benzenetriol, 5-(2-aminoethyl)-","5-(2-Aminoethyl)-1,2,4-benzenetriol","CCRIS 4342","4-13-00-02916","6 Hydroxydopamine"],"CAS":"1199-18-4","ChEBI":"CHEBI:78741","ChEMBL":"CHEMBL337702","ChemicalClasses":["catecholamine"],"Chirality":"achiral","Classes":["Neurotoxin"],"Dosing Info":[],"DrugClasses":[],"EINECS":"214-842-3","European Community (EC) Number":"214-842-3","FullSalts":["Oxidopamine hydrobromide","Oxidopamine hydrochloride"],"HMDB ID":"HMDB0001537","HeavyAtomCount":12,"IUPACName":"5-(2-aminoethyl)benzene-1,2,4-triol","InChI":"InChI=1S/C8H11NO3/c9-2-1-5-3-7(11)8(12)4-6(5)10/h3-4,10-12H,1-2,9H2","InChIKey":"DIVDFFZHCJEHGG-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)","Melting Point":"232 °C","MolecularFormula":"C\u003csub\u003e8\u003c/sub\u003eH\u003csub\u003e11\u003c/sub\u003eNO\u003csub\u003e3\u003c/sub\u003e","MolecularWeight":"169.18 g/mol","Physical Description":"6-hydroxydopamine is a solid. Used as a pharmacological agent.","PrevSalts":["hydrobromide","hydrochloride"],"PubChemId":4624,"Record Description":["6-hydroxydopamine is a solid. Used as a pharmacological agent.","Oxidopamine is a benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease). It has a role as a neurotoxin, a human metabolite and a drug metabolite. It is a primary amino compound, a benzenetriol and a catecholamine. It is functionally related to a dopamine.","Oxidopamine is an antagonist of the neurotransmitter dopamine with potential antineoplastic activity. 6-Hydroxydopamine (6-HOD) can be taken up by selective adrenergic terminals, thereby causing acute degeneration of adrenergic terminals that leads to depletion of norepinephrine, and of dopamine in the dopamine-sensitive sites. This agent is auto-oxidated at physiological pH that leads to the formation of reactive free radicals, thereby leading to cytotoxicity in neural cells.  6-Hydroxydopamine is often used to induce CNS and sympathetic neural lesions that model aging and various nervous disorders in animal systems.","A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.","Oxidopamine is a benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease). It has a role as a neurotoxin, a human metabolite and a drug metabolite. It is a primary amino compound, a benzenetriol and a catecholamine. It is functionally related to a dopamine."],"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Oxidopamine","Name":"Oxidopamine","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q780181","Name":"Oxidopamine","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/4624","Name":"Oxidopamine","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL337702","Name":"Oxidopamine","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:78741","Name":"Oxidopamine","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=1199-18-4","Name":"Oxidopamine","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0001537","Name":"Oxidopamine","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/D05294","Name":"Oxidopamine","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/8HW4YBZ748","Name":"Oxidopamine","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID0036768","Name":"Oxidopamine","Sub":false}]}],"SMILES":"C1=C(C(=CC(=C1O)O)O)CCN","Salts":["hydrobromide","hydrochloride"],"SaltsAcidCount":[1,1],"SaltsAmineCount":[1,1],"SaltsUNII":["TWC1D4W0WB","9WBV30HXTL"],"StoreUNII":["8HW4YBZ748"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="36.655mm" version="1.2" viewBox="0 0 95.633 36.655" width="95.633mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#FF0D0D" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="37.0" stroke="none" width="96.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <g class="bond" id="mol1bnd1">
                        
                <line x1="46.726" x2="33.523" y1="10.707" y2="3.079"/>
                        
                <line x1="44.288" x2="33.523" y1="12.115" y2="5.895"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd2" x1="46.726" x2="46.731" y1="10.707" y2="25.956"/>
                  
            <g class="bond" id="mol1bnd3">
                        
                <line x1="33.533" x2="46.731" y1="33.576" y2="25.956"/>
                        
                <line x1="33.533" x2="44.292" y1="30.76" y2="24.548"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd4" x1="33.533" x2="20.33" y1="33.576" y2="25.947"/>
                  
            <g class="bond" id="mol1bnd5">
                        
                <line x1="20.325" x2="20.33" y1="10.699" y2="25.947"/>
                        
                <line x1="22.764" x2="22.768" y1="12.107" y2="24.54"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd6" x1="33.523" x2="20.325" y1="3.079" y2="10.699"/>
                  
            <line class="bond" id="mol1bnd7" x1="20.325" x2="10.401" y1="10.699" y2="4.972"/>
                  
            <line class="bond" id="mol1bnd8" x1="20.33" x2="10.41" y1="25.947" y2="31.675"/>
                  
            <line class="bond" id="mol1bnd9" x1="46.731" x2="56.646" y1="25.956" y2="31.678"/>
                  
            <line class="bond" id="mol1bnd10" x1="46.726" x2="59.924" y1="10.707" y2="3.087"/>
                  
            <line class="bond" id="mol1bnd11" x1="59.924" x2="73.123" y1="3.087" y2="10.707"/>
                  
            <line class="bond" id="mol1bnd12" x1="73.123" x2="83.168" y1="10.707" y2="4.908"/>
                  
            <g class="atom" id="mol1atm7">
                        
                <path d="M9.385 3.078q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.733 -.0 1.233 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM5.521 3.078q.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" stroke="none"/>
                        
                <path d="M4.305 5.531h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62v4.9z" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm8">
                        
                <path d="M9.391 33.565q-.0 .756 -.256 1.327q-.256 .566 -.756 .881q-.5 .316 -1.245 .316q-.756 -.0 -1.262 -.316q-.506 -.315 -.756 -.887q-.244 -.571 -.244 -1.333q.0 -.75 .244 -1.31q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.733 .0 1.233 .316q.5 .309 .756 .875q.256 .566 .256 1.328zM5.527 33.565q.0 .922 .387 1.458q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.458q-.0 -.929 -.387 -1.453q-.381 -.524 -1.209 -.524q-.833 .0 -1.226 .524q-.393 .524 -.393 1.453z" stroke="none"/>
                        
                <path d="M4.311 36.017h-.62v-2.286h-2.512v2.286h-.613v-4.899h.613v2.071h2.512v-2.071h.62v4.899z" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm9">
                        
                <path d="M62.19 33.571q-.0 .756 -.256 1.327q-.256 .566 -.756 .881q-.5 .316 -1.244 .316q-.757 -.0 -1.263 -.316q-.506 -.315 -.756 -.887q-.244 -.571 -.244 -1.333q.0 -.75 .244 -1.31q.25 -.565 .756 -.881q.506 -.315 1.274 -.315q.733 -.0 1.233 .315q.5 .31 .756 .875q.256 .566 .256 1.328zM58.326 33.571q.0 .923 .387 1.458q.393 .53 1.221 .53q.839 .0 1.22 -.53q.387 -.535 .387 -1.458q-.0 -.929 -.387 -1.453q-.381 -.524 -1.209 -.524q-.833 .0 -1.226 .524q-.393 .524 -.393 1.453z" stroke="none"/>
                        
                <path d="M66.496 36.024h-.619v-2.286h-2.512v2.286h-.614v-4.9h.614v2.072h2.512v-2.072h.619v4.9z" stroke="none"/>
                      
            </g>
                  
            <g class="atom" id="mol1atm12">
                        
                <path d="M88.262 5.537h-.721l-2.619 -4.066h-.03q.012 .238 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.715l2.607 4.054h.03q-.006 -.107 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.768h.578v4.899z" fill="#3050F8" stroke="none"/>
                        
                <path d="M92.568 5.537h-.619v-2.286h-2.513v2.286h-.613v-4.899h.613v2.071h2.513v-2.071h.619v4.899z" fill="#3050F8" stroke="none"/>
                        
                <path d="M95.073 7.027h-1.944v-.3l.772 -.779q.221 -.221 .371 -.393q.154 -.175 .233 -.339q.078 -.168 .078 -.365q.0 -.242 -.146 -.367q-.143 -.129 -.372 -.129q-.214 -.0 -.378 .075q-.161 .075 -.329 .207l-.193 -.243q.172 -.146 .393 -.246q.225 -.1 .507 -.1q.411 -.0 .65 .207q.24 .207 .24 .575q-.0 .229 -.097 .432q-.093 .2 -.264 .397q-.168 .196 -.393 .418l-.614 .603v.018h1.486v.329z" fill="#3050F8" stroke="none"/>
                      
            </g>
                
            <line class="hi" id="mol1bnd7" stroke="#FF0D0D" x1="10.401" x2="15.363" y1="4.972" y2="7.8355"/>
            <line class="hi" id="mol1bnd7" stroke="#FF0D0D" x1="10.401" x2="15.363" y1="4.972" y2="7.8355"/>
            <line class="hi" id="mol1bnd8" stroke="#FF0D0D" x1="10.41" x2="15.37" y1="31.675" y2="28.811"/>
            <line class="hi" id="mol1bnd8" stroke="#FF0D0D" x1="10.41" x2="15.37" y1="31.675" y2="28.811"/>
            <line class="hi" id="mol1bnd9" stroke="#FF0D0D" x1="56.646" x2="51.688500000000005" y1="31.678" y2="28.817"/>
            <line class="hi" id="mol1bnd12" stroke="#3050F8" x1="83.168" x2="78.1455" y1="4.908" y2="7.807500000000001"/>
        </g>
          
    </g>
    
</svg>
","Title":"Oxidopamine","UNII":"8HW4YBZ748","Wikidata":"Q780181","Wikipedia":"Oxidopamine","XLogP":0.2}